Crispr Therapeutics AG (crsp 1.7308 03/01/31)
13F holders, Q1 2026 (March 31)1holders
$0.98avg. 13F price*
At the end of Q1 2026, 1 institutions reported holding Crispr Therapeutics AG (crsp 1.7308 03/01/31) in their 13F filings. The largest holder was Ghisallo Capital Management LLC ($3.9M).
- Company
- Crispr Therapeutics AG (crsp 1.7308 03/01/31)
- Filed as
- CRSP 1.731 03/01/31 CVT (Q1 2026)
- CUSIP
- 226712AA5
- Latest filing quarter
- Q1 2026
Total Exit/New Position Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $3.9M |
| Exits | 0 | $0 |
Ownership 1 holders
| Ghisallo Capital Management LLC | 0.11% | New | 4,000,000 | $3.9M |
"% of holder's portfolio" is CRISPR THERAPEUTICS AG (CRSP 1.7308 03/01/31)'s weight in each manager's 13F, not the share of Crispr Therapeutics AG (crsp 1.7308 03/01/31) the manager owns.